References
- Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA-Cancer J Clinicians. 2018;68(1):7–30. doi:https://doi.org/10.3322/caac.21442
- Lin Y, Totsuka Y, He Y, Kikuchi S, Qiao Y, Ueda J, Wei W, Inoue M, Tanaka H. Epidemiology of esophageal cancer in Japan and China. J Epidemiol. 2013;23(4):233–42. doi:https://doi.org/10.2188/jea.je20120162
- Huang FL, Yu SJ. Esophageal cancer: risk factors, genetic association, and treatment. Asian J Surg. 2018;41(3):210–5. doi:https://doi.org/10.1016/j.asjsur.2016.10.005
- Shitara K, Matsuo K, Hatooka S, Ura T, Takahari D, Yokota T, Abe T, Kawai H, Tajika M, Kodaira T, et al. Heavy smoking history interacts with chemoradiotherapy for esophageal cancer prognosis: a retrospective study. Cancer Sci. 2010;101(4):1001–6. doi:https://doi.org/10.1111/j.1349-7006.2009.01466.x
- Pandeya N, Williams G, Green AC, Webb PM, Whiteman DC. Alcohol consumption and the risks of adenocarcinoma and squamous cell carcinoma of the esophagus. Gastroenterology. 2009;136(4):1215–24. doi:https://doi.org/10.1053/j.gastro.2008.12.052
- Bozzetti F, Mariani L, Lo Vullo S, Amerio ML, Biffi R, Caccialanza G, Capuano G, Capuano G, Correja I, Cozzaglio L, SCRINIO Working Group, et al. The nutritional risk in oncology: a study of 1,453 cancer outpatients. Support Care Cancer. 2012;20(8):1919–28. doi:https://doi.org/10.1007/s00520-012-1387-x
- Sun K, Chen S, Xu J, Li G, He Y. The prognostic significance of the prognostic nutritional index in cancer: a systematic review and meta-analysis. J Cancer Res Clin Oncol. 2014;140(9):1537–49. doi:https://doi.org/10.1007/s00432-014-1714-3
- Wang D, Hu X, Xiao L, Long G, Yao L, Wang Z, Zhou L. Prognostic nutritional index and systemic immune-inflammation index predict the prognosis of patients with HCC. J Gastrointest Surg. 2020 Feb 5. doi:10.1007/s11605-019-04492-7
- Yang Y, Gao P, Chen X, Song Y, Shi J, Zhao J, Sun J, Xu Y, Wang Z. Prognostic significance of preoperative prognostic nutritional index in colorectal cancer: results from a retrospective cohort study and a meta-analysis. Oncotarget. 2016;7(36):58543–52. doi:https://doi.org/10.18632/oncotarget.10148
- Kanda M, Fujii T, Kodera Y, Nagai S, Takeda S, Nakao A. Nutritional predictors of postoperative outcome in pancreatic cancer. Br J Surg. 2011;98(2):268–74. doi:https://doi.org/10.1002/bjs.7305
- Nozoe T, Ninomiya M, Maeda T, Matsukuma A, Nakashima H, Ezaki T. Prognostic nutritional index: a tool to predict the biological aggressiveness of gastric carcinoma. Surg Today. 2010;40(5):440–3. doi:https://doi.org/10.1007/s00595-009-4065-y
- Dai Y, Fu X, Li T, Yao Q, Su L, Su H, Li J. Long-term impact of prognostic nutritional index in cervical esophageal squamous cell carcinoma patients undergoing definitive radiotherapy. Ann Transl Med. 2019;7(8):175. doi:https://doi.org/10.21037/atm.2019.03.60
- Hoeben A, Polak J, Van De Voorde L, Hoebers F, Grabsch HI, de Vos-Geelen J. Cervical esophageal cancer: a gap in cancer knowledge. Ann Oncol. 2016;27(9):1664–74. doi:https://doi.org/10.1093/annonc/mdw183
- Proctor MJ, Morrison DS, Talwar D, Balmer SM, Fletcher CD, O’Reilly DSJ, Foulis AK, Horgan PG, McMillan DC. A comparison of inflammation-based prognostic scores in patients with cancer. A Glasgow Inflammation Outcome Study. Eur J Cancer. 2011;47(17):2633–41. doi:https://doi.org/10.1016/j.ejca.2011.03.028
- Gangopadhyay A. Prognostic nutritional index and clinical response in locally advanced cervical cancer. Nutr Cancer. 2020 Feb 24:1-5. Epub ahead of print. doi:https://doi.org/10.1080/01635581.2020.1729820
- Nakatani M, Migita K, Matsumoto S, Wakatsuki K, Ito M, Nakade H, Kunishige T, Kitano M, Kanehiro H. Prognostic significance of the prognostic nutritional index in esophageal cancer patients undergoing neoadjuvant chemotherapy. Dis Esophagus. 2017;30(8):1–7. doi:https://doi.org/10.1093/dote/dox020
- Hirahara N, Tajima Y, Fujii Y, Kaji S, Yamamoto T, Hyakudomi R, Taniura T, Miyazaki Y, Kishi T, Kawabata Y. Preoperative prognostic nutritional index predicts long-term surgical outcomes in patients with esophageal squamous cell carcinoma. World J Surg. 2018;42(7):2199–2208. doi:https://doi.org/10.1007/s00268-017-4437-1
- Han L, Song Q, Jia Y, Chen X, Wang C, Chen P, Min R, Cheng Y. The clinical significance of systemic inflammation score in esophageal squamous cell carcinoma. Tumour Biol. 2016;37(3):3081–3090. doi:https://doi.org/10.1007/s13277-015-4152-1
- Tsunemoto H, Ishikawa T, Morita S, Kitagawa T, Tsujii H. Indications of particle radiation therapy in the treatment of carcinoma of the esophagus. Int J Radiat Oncol Biol Phys. 1992;22(2):321–4. doi:https://doi.org/10.1016/0360-3016(92)90049-n
- Stahl M, Stuschke M, Lehmann N, Meyer H-J, Walz MK, Seeber S, Klump B, Budach W, Teichmann R, Schmitt M, et al. Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus. JCO. 2005;23(10):2310–7. doi:https://doi.org/10.1200/JCO.2005.00.034
- Wulaningsih W, Holmberg L, Garmo H, Malmstrom H, Lambe M, Hammar N, Walldius G, Jungner I, Van Hemelrijck M. Prediagnostic serum inflammatory markers in relation to breast cancer risk, severity at diagnosis and survival in breast cancer patients. Carcinogenesis. 2015;36(10):1121–8. doi:https://doi.org/10.1093/carcin/bgv096
- Suh B, Park S, Shin DW, Yun JM, Keam B, Yang HK, Ahn E, Lee H, Park JH, Cho B. Low albumin-to-globulin ratio associated with cancer incidence and mortality in generally healthy adults. Ann Oncol. 2014;25(11):2260–6. doi:https://doi.org/10.1093/annonc/mdu274
- Gupta D, Lis CG. Pretreatment serum albumin as a predictor of cancer survival: a systematic review of the epidemiological literature. Nutr J. 2010;9:69. doi:https://doi.org/10.1186/1475-2891-9-69
- von Bernstorff W, Voss M, Freichel S, Schmid A, Vogel I, Johnk C, Henne-Bruns D, Kremer B, Kalthoff H. Systemic and local immunosuppression in pancreatic cancer patients. Clin Cancer Res. 2001;7(3 Suppl):925s–932s.
- Whiteside TL. Tricks tumors use to escape from immune control. Oral Oncol. 2009;45(10):e119–e123. doi:https://doi.org/10.1016/j.oraloncology.2009.03.006
- Kerkar SP, Restifo NP. Cellular constituents of immune escape within the tumor microenvironment. Cancer Res. 2012;72(13):3125–30. doi:https://doi.org/10.1158/0008-5472.CAN-11-4094